Myomo names Mary-Katherine McClure chief commercial officer as Micah Mitchell exits

By Public Technologies
  • Myomo named Mary-Katherine “Katie” McClure chief commercial officer, effective Oct. 12, 2026.
  • McClure joins from Inspire Medical Systems, where she worked since 2018 amid revenue growth from about $50 million to nearly $1 billion.
  • Earlier roles included senior medical device sales posts at Medtronic, Tobii Dynavox, Johnson & Johnson.
  • Outgoing chief commercial officer Micah Mitchell will depart following a transition period ending Dec. 23, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Myomo Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610121605BIZWIRE_USPR_____20261012_BW506126) on October 12, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.